AngioDynamics’ DIRECT clinical study receives IRB approval for treating stage III pancreatic cancer
Image: AngioDynamics’ DIRECT clinical study receives IRB approval for treating stage III pancreatic cancer. Photo: Courtesy of rajcreationzs/FreeDigitalPhotos.net